Episodes 1-15 of 41
Early Action in Obesity: Transforming Practice, Improving Outcomes
CME/CEEarly Action in Obesity: Transforming Practice, Improving Outcomes
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CECase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CERisk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CEChairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
CME/CEContinuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
- advertisement
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
CME/CEStemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
CME/CEThe Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®APOC3 Inhibition: A Novel Approach to Lowering TGs
- advertisement
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®Latest Clinical Trial Outcomes and Breakthroughs for FCS
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®SHTG: Decoding the Latest Clinical Trial Outcomes









































































